scholarly article | Q13442814 |
P356 | DOI | 10.1007/S12020-017-1387-1 |
P698 | PubMed publication ID | 28822077 |
P2093 | author name string | Yuming Wang | |
Xiaowei Liu | |||
Wenjing Zhou | |||
Jinzhou Zhu | |||
Lijiang Tang | |||
Qinyi Zhou | |||
Changqing Du | |||
Kefu Zhu | |||
Chenkai Xu | |||
Pengqin Shu | |||
P2860 | cites work | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association | Q22241921 |
Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A | Q24530543 | ||
Fetuin-B, a second member of the fetuin family in mammals | Q24532137 | ||
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q27860791 | ||
Type 3 cystatins; fetuins, kininogen and histidine-rich glycoprotein | Q28237700 | ||
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
Electronegative low-density lipoprotein: origin and impact on health and disease | Q37835483 | ||
Fetuin-A and the cardiovascular system. | Q37991344 | ||
Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis | Q38232998 | ||
Proteomic and transcriptomic analysis for streptozotocin-induced diabetic rat pancreas in response to fungal polysaccharide treatments | Q38291342 | ||
The serum protein fetuin-B is involved in the development of acute myocardial infarction | Q38910796 | ||
Coronary Plaque Disruption | Q40459835 | ||
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance | Q42832316 | ||
Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans | Q45038131 | ||
Association of high fetuin-B concentrations in serum with fertilization rate in IVF: a cross-sectional pilot study | Q47916637 | ||
Acute stress evokes selective mobilization of T cells that differ in chemokine receptor expression: a potential pathway linking immunologic reactivity to cardiovascular disease | Q48268328 | ||
Regulation of the novel adipokines/ hepatokines fetuin A and fetuin B in gestational diabetes mellitus. | Q50901508 | ||
Association of high alpha2-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass. | Q51488638 | ||
Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study. | Q51507173 | ||
Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism. | Q53265229 | ||
Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis | Q77718606 | ||
Preparation and properties of the human plasma Ba-alpha2-glycoproteins | Q79021695 | ||
Inflammation and atherosclerosis | Q81432059 | ||
Plasma proteome analysis in diet-induced obesity-prone and obesity-resistant rats | Q82773887 | ||
2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat | Q86690927 | ||
Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes | Q87396359 | ||
P577 | publication date | 2017-08-19 | |
P1433 | published in | Endocrine | Q15757048 |
P1476 | title | Increased serum levels of fetuin B in patients with coronary artery disease |
Q58778044 | Fetuin B links vitamin D deficiency and pediatric obesity: Direct negative regulation by vitamin D |
Q91891756 | Increased serum fetuin-B concentration is associated with HOMA-β and indices of liver steatosis in women with polycystic ovary syndrome: a pilot study |
Q90138898 | Upregulated hepatokine fetuin B aggravates myocardial ischemia/reperfusion injury through inhibiting insulin signaling in diabetic mice |
Search more.